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PREVALENCE AND SEVERITY OF NEUROPSYCHIATRIC SYMPTOMS IN 
EARLY VERSUS LATE ONSET ALZHEIMER’S DISEASE 
 
ABSTRACT 
Background: The study aimed to compare neuropsychiatric symptoms (NPS) in people with 
early onset Alzheimer’s disease (EOAD) and late onset AD (LOAD). 
Methods: 56 LOAD and 24 EOAD participants with mild dementia were assessed for NPS 
for their frequency, severity and caregiver distress as measured by neuropsychiatry inventory 
(NPI) along with assessments of cognition and functional dependence. 
Results: EOAD and LOAD participants were not significantly different for total NPI score 
(p=0.057). EOAD had greater prevalence of all the NPS except apathy. EOAD participants 
were significantly worse on anxiety (p=0.03), irritability (p=0.01) and sleep (p<0.01) 
subscales and their carers significantly more distressed by their irritability (p=0.002) and 
sleeping patterns (p=0.005). Regression analysis showed that higher NPI score was 
associated with longer duration of illness in EOAD and higher functional dependence in 
LOAD.  
Conclusions: The NPS severity was similar between EOAD and LOAD although EOAD had 
higher symptom prevalence and carer distress.  
Key words:  
Alzheimer’s disease, early-onset Alzheimer’s disease, Neuropsychiatric symptoms, 
Neuropsychiatry Inventory, caregiver stress 
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Introduction 
Dementia is a neurodegenerative disorder affecting over 46 million people worldwide 
and Alzheimer’s disease (AD) is the most common form of dementia, which typically occur 
in late life but in approximately 4 percent of cases it occurs in people younger than 65 years 
old (early onset) 1-3. Although the underlying neuropathological hallmarks are the same, there 
is some evidence that there are differences in aspects of the disease between early onset AD 
(EOAD) and late onset AD (LOAD). Research has suggested that the rate of progression of 
the disease is more rapid in EOAD 4,5, that there are differences in the distribution of atrophy 
in the grey matter 6 and genetic differences 5.  Other studies have shown differences in the 
initial clinical presentation of the illness 7 and the pattern of types of memory problems 
between EOAD and LOAD 8-11. Studies have demonstrated EOAD have greater behavioural 
problems, more rapid cognitive decline and increased language difficulties 12. In addition, the 
earliest symptoms of dementia in those under 65 years are typically non-amnestic 13 and may 
contribute to the delay in diagnosis. 
Neuropsychiatric symptoms (NPS) in dementia have been found to complicate the 
course and management of the disease, and has been associated with accelerated progression 
of cognitive decline 14 and an increased risk for early institutionalization 15. Much research 
has identified the presence of NPS in late onset dementia 16-21 and some previous studies 
found higher NPS in EOAD, mostly affective symptoms 22-25. However, there were 
variabilities in the two groups in terms of a difference in MMSE or disease severity and 
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functional abilities between the groups. Presence of NPS in early onset cases may delay the 
diagnosis, as it can often be misinterpreted as primary psychiatric condition, rather than 
associated with neurodegenerative disorders 26. A recent review 27 has called for studies using 
consistent measures of NPS, examining NPS individually and the distress caused to 
caregivers by them. Further clarifying these is important for clinical care, especially as little 
is known about caregiver distress in EOAD. This study aims to compare prevalence of 
individual NPS, severity and impact on carers as indicated by carers’ distress between EOAD 
and LOAD patients, as indicated by their scores on the Neuropsychiatric Inventory (NPI) 28.   
 
Methods 
Subjects 
AD participants (with a Mini Mental State Examination score, MMSE; 15-25), late 
onset AD (LOAD; n=58) who had onset after the age of 65 years and early onset AD 
(EOAD; n=24), who had onset of illness before 65 years of age, were recruited from 
consecutive referrals from memory services of the South London and Maudsley (SLaM) NHS 
Foundation Trust, UK and Leicestershire Partnership NHS Trust, UK. Diagnosis of probable 
Alzheimer’s disease was made for all participants according to the National Institute of 
Neurological and Communicative Diseases and Stroke/Alzheimer’s Disease and Related 
Disorders Association (NINCDS-ADRDA) criteria  29. The exclusion criteria were: dementia 
other than AD; history of neurological disorder or major psychiatric disorder, including 
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substance abuse: and absence of a carer to provide information for NPI. Patients were 
excluded if they were between 65-70 years in order to ensure that individuals who were 
diagnosed with AD after 65 years of age had not developed symptoms before they were 65 
years old but had delayed diagnosis.  Two patients were excluded for this reason - 67-year-
old male (25/30 on MMSE, NPI score of 3 and 6 months of illness duration) and a 69-year-
old female (13/30 on MMSE, NPI score of 7 and 24 months of illness duration). 
All participants gave informed consent to participate in the study. The study had 
ethics approval from the regional Research Ethics Committee. 
 
Assessments: 
Assessments included cognitive testing with MMSE 30; non-cognitive symptoms 
using Neuropsychiatric Inventory (NPI) 28 which was completed with the carer, and daily 
activities with Bristol Activities of Daily Living Scale (BADLS)31. Information pertaining to 
the participant’s family history of memory problems, duration of illness, and the number of 
years of education were elicited from the participant and their carer.   
The Neuropsychiatric Inventory (NPI) measures the frequency and severity of 12 
psychiatric and behavioural symptoms/domains (Neuropsychiatric symptoms, NPS) on the 
basis of caregiver report 28 (delusions, hallucinations, agitation/aggression, 
depression/dysphoria, anxiety, elation, apathy/indifference, disinhibition, irritability/lability, 
aberrant motor behaviour, sleep disturbance, and appetite and eating disorder)32. For each 
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domain, the NPI begins with a screening question (Yes or No, to indicate presence versus 
absence of this symptom), followed by 7–8 more specific follow up questions to determine 
the nature of the overall symptom endorsed (again, in Yes/No format). The caregiver were 
asked to rate the overall frequency1–4 and severity 1–3 of all the symptoms, thus providing 
an overall index of symptom severity. Test– retest reliabilities for this measure range from 
0.64 to 0.71 32,33. The caregiver also scored their own distress for the individual patient’s 
symptoms (scores range from 0-5) and the total caregiver distress score was calculated. 
 
Statistical Analysis 
Statistical analysis was performed using IBM SPSS statistics version 24. Non-
parametric analyses were performed as the data showed non-normal distribution. Chi-squared 
tests were used to explore differences on categorical data (with Fisher’s Exact test for 
multiple analyses) and Mann-Whitney U tests for continuous variables.  Analyses were 
carried out to explore the differences between EOAD and LOAD groups in terms of family 
history of memory problems, duration of symptoms, and the number of years of education as 
well as total NPI (sum of frequency x severity subscale scores) and NPI-subscale scores 
(frequency x severity) and carer distress score (individual NPS and total). Linear regression 
analysis was carried out with NPI total as dependent variable and MMSE, age, gender, 
education, duration of illness, family history and ADL entered as the predictive variables. 
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Results 
There were 56 patients in the LOAD group and 24 patients in the EOAD group. Table 
1 shows demographic data for each group. The EOAD group had significantly longer 
duration of symptoms at the time of assessment than the LOAD group (Mann-Whitney U, 
P<0.01) but were not significantly different in terms of gender, years of education, family 
history of dementia, MMSE or BADL score.  The participants were mostly White British 
except 4 Asian in EOAD group and 3 Afro-Caribbean in LOAD group. The EOAD groups 
had a higher proportion of individuals with a family history of dementia but this was not 
statistically significant (Chi2 =2.23, P=0.14). 
The 2 groups were not different for previous psychiatry history (i.e., depression, or 
anxiety) or use of antidepressants. No patients had history of previous psychosis or substance 
related disorder. None of the patients on the LOAD group had been commenced on anti-
dementia medications at the point of assessments. 14 (58%) EOAD patients were commenced 
on one or other of the anti-dementia medications [donepezil (10), galantamine (3) or 
memantine (1)]. This was because interested LOAD participants could be recruited soon after 
their clinical assessments and diagnosis, however this was not possible for EOAD patients 
due to unavailability of carers who were working or had childcare responsibilities, and some 
patients and carers needed more time to accept and adapt to the AD diagnosis before 
participation. However, there was no difference in total NPI scores (p=0.141) or carer distress 
(p=0.189) between EOAD patients with and without anti-dementia medications. 
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The overall total NPI score was not significantly different for the EOAD group 
compared to LOAD (Mann-Whitney U, p=0.057). However, the EOAD patients had higher 
prevalence of all symptoms except apathy and scored higher (symptom frequency x severity) 
than the LOAD group on the Anxiety, Irritability and Sleep subscales (Table 2).  Figure 1 
shows the percentage of participants in each group who reported symptoms in each subscale.  
The total carer distress was higher for EOAD although not statistically significant. However, 
when tested for individual NPS, the carers’ distress was significantly higher in EOAD group 
for irritability (Mann-Whitney U, p=0.002) and sleeping patterns (Mann-Whitney U, 
p=0.005) (Table 2).   
Linear regression analysis with NPI total as the dependent variable and MMSE, age, 
gender, education, duration of illness, family history and ADL (Model 1) as independent 
variables, showed longer duration of illness and higher ADL dependence as predictors for the 
whole cohort.  In the LOAD group higher ADL dependence, and in the EOAD group 
duration of illness predicted the total NPI score (Table 3). 
 
Discussion 
The study aimed to compare patients with early-onset and late-onset Alzheimer’s 
disease in terms of prevalence and severity of NPS as measured by the NPI. We found that 
the overall total NPS severity score was similar for the EOAD group compared to LOAD. 
The prevalence of 12 NPS as reported on the NPI was higher except for apathy in the EOAD 
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group compared to LOAD and significantly higher for the Anxiety, Irritability and Sleep 
subscales.  The EOAD group were comparable to the LOAD group except that they had 
longer illness duration. Our study demonstrated that longer duration of illness and greater 
ADL dependence affected the total NPS for the whole cohort.  For people with LOAD, 
higher ADL dependence predicted NPI total score and for EOAD, longer duration of illness 
predicted NPI total. 
Neuropsychiatric symptoms are common in Alzheimer’s disease although the 
prevalence and frequency vary across studies. Our findings are in keeping with previous 
studies which found higher NPS prevalence in EOAD 22-25. The prevalence of anxiety and 
depression has been reported to be greater in EOAD samples in various studies 22,23,25. This is 
thought to be due to both the diagnosis and the subsequent changes in lifestyle, roles, and 
responsibility 34 which are greater in EOAD than LOAD. Another study showed that NPS 
increased with the severity of dementia in patients with EOAD; with apathy, agitation, 
disinhibition, irritability and aberrant motor behaviour worsening with severity as in later 
onset AD, however with different patterns for hallucinations (occurring in milder stages due 
to brain damage), depression and anxiety (occurring throughout the course both due to brain 
damage and psychosocial factors) in EOAD 35. 
Conversely, LOAD patients have been reported with a higher NPI total score than the 
EOAD group, with higher scores on the delusion, hallucination, agitation, disinhibition and 
aberrant motor behaviour subscales and with similar duration of the illness and measures of 
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disease severity 16. A two-year longitudinal study of NPS in early-onset and late-onset AD, 
found that the incidence and prevalence of NPS were lower in EOAD than in LOAD – in 
particular delusions, agitation, depression, apathy, anxiety, aberrant motor behaviour and 
irritability 19.  Another study 36 compared EOAD and LOAD groups with similar severity, 
and found LOAD patients had higher total NPI score, and delusion, agitation, and night-time 
behavioural disturbance subscale scores. However, the EOAD group was less impaired in 
ADL and Instrumental ADL. The authors suggested that EOAD patients have greater 
cognitive reserve, associated with higher levels of education, which enabled them to 
compensate for cognitive deterioration and maintain levels of functioning and reduce the 
impact of behavioural symptoms. A recent study found that the LOAD group scored higher 
on total NPI score but had lower MMSE scores than the EOAD group 21.  Other studies have 
found EOAD and LOAD patients similar in total frequency and severity of NPS, although 
there seemed to be different symptom profiles in the two groups37. 
In keeping with previous studies, our EOAD patients were treated with cholinesterase 
inhibitors to a higher extent than those with LOAD 38, while there were no differences 
between the groups in antidepressant and antipsychotics use. 
In our study the EOAD group had longer duration of illness which may have 
contributed to the higher NPS prevalence, although they were similar in their NPS severity to 
LOAD.  The EOAD patients had functional dependence (ADL scores) similar to LOAD who 
had shorter duration of illness, indicating better reserve and compensatory mechanisms in 
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EOAD patients. Our cohort of EOAD had longer duration of illness compared to LOAD 
possibly due to the longer time taken to diagnosis which is known to occur in early onset 
dementia 39. Diagnosing young onset dementia is challenging and the range of possible 
presenting features is broad, encompassing behavioural, cognitive, psychiatric and 
neurological domains, and symptoms are often subtle initially 40. Since approximately one-
third patients of younger age present with an atypical nonmemory phenotype41 translating to 
delayed diagnosis and NPS are confounding factors, it is important that clinicians give 
importance to specific symptoms.  
The carer distress was higher for EOAD and significantly so for irritability and sleep 
symptoms on NPI. Most of the studies that have reported carer distress associated with NPS 
have been for LOAD. A recent meta-analysis found irritability one of the symptoms most 
strongly correlated to distress 27. Irritability was also reported to be signiﬁcantly associated 
with caregiver burden 42,43. To our knowledge our study is the first one to compare the carer 
distress between the EOAD and LOAD for individual symptoms. The early recognition and 
management of specific NPS by family members and health professionals may lead to better 
care and quality of life for both patients and caregivers. It is important to look further into 
caregiver factors and examine the causal mechanisms by which NPS impact caregiver well-
being and burden, so that interventions can be designed to target NPS more effectively and to 
also support caregivers.  
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The strength of the study is that standardised measures were used for diagnosis and to 
evaluate neuropsychiatric symptoms. We also excluded patients aged between 65 to 70 years, 
giving a ‘buffer’ of 5 years between younger & older onset participants, & excluded people 
with history of psychiatric disorder. The exclusion of LOAD participants between the ages of 
65 and 70 may potentially have been a source of bias, but it was felt that the benefit in terms 
of separating the two groups was greater.  The small sample is the main limitation of the 
study, but nonetheless, the findings have implications for diagnosis and management of NPS 
in AD patients. Although the two groups were comparable for MMSE, additional cognitive 
measures for severity assessment would have been useful. However, ADL were assessed, and 
both the groups were comparable for level of functional abilities. Analyses were carried out 
without controlling for multiple comparisons, and so results should be considered as 
preliminary until confirmed in a larger study.  
In conclusion, the NPS severity was similar between EOAD and LOAD groups with 
similar dementia severity, although EOAD patients had higher symptom prevalence and carer 
distress. Detection of NPS is important as they impact negatively upon the ADL, cognitive 
functioning and quality of life for patients and have been shown to increase caregiver stress 
and impact upon the likelihood of admission to institutional care. Understanding the pattern 
of NPS in AD is important when planning treatment, services and care. Future research using 
larger samples and longitudinal study is needed in order to characterize the different reasons 
for NPS in EOAD and LOAD and mechanisms for alleviating it. 
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